Observational study finds cannabis use doubles risk of serious mental disorders in adolescents — Evidence Review
Published in JAMA Health Forum, by researchers from Kaiser Permanente, Public Health Institute, University of California, San Francisco, University of Southern California
Researched by
— the AI search engine for science
Table of Contents
Adolescent cannabis use is associated with significantly increased risks of developing psychotic, bipolar, depressive, and anxiety disorders by early adulthood, according to a large-scale longitudinal study. The findings from Kaiser Permanente and collaborators are broadly consistent with decades of prior research linking early cannabis exposure to later psychiatric illness.
- Numerous previous studies have shown that adolescent cannabis use is linked to higher risks of psychosis, mood disorders, and suicidality, with some evidence suggesting a dose-response effect and particular vulnerability associated with heavier or earlier use 1 3 4 6 7 8 10 13.
- Evidence regarding the association between cannabis use and depression or anxiety is more mixed, with some meta-analyses and systematic reviews noting moderate risk elevations, while others highlight inconsistent findings or possible reverse causality 1 2 13 15.
- The increased risks associated with high-potency cannabis use and adolescent initiation, as identified in the new study, are supported by recent European and meta-analytic research showing higher rates of psychotic disorders and mania among young cannabis users, especially with frequent or high-THC products 2 7 8 11 13.
Study Overview and Key Findings
Growing legalization, increased product potency, and aggressive marketing have led to greater adolescent exposure to cannabis, but the mental health consequences remain a pressing public health concern. This study stands out due to its exceptionally large sample size and its use of routinely collected electronic health records, enabling researchers to track the temporal relationship between self-reported cannabis use and later psychiatric diagnoses. Unlike many previous investigations, this research included all levels of cannabis use, not just heavy or disordered patterns, and controlled for confounders such as prior mental health conditions and other substance use.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Kaiser Permanente, Public Health Institute, University of California, San Francisco, University of Southern California |
| Journal Name | JAMA Health Forum |
| Authors | Kelly C. Young-Wolff, Catherine A. Cortez, Stacey E. Alexeeff, Lynn D. Silver, Rosalie Liccardo Pacula, Natalie E. Slama, Alisa A. Padon, Derek D. Satre, Cynthia I. Campbell, Maria T. Koshy, Monique B. Does, Stacy A. Sterling |
| Population | Adolescents ages 13 to 17 |
| Sample Size | n=463,396 |
| Methods | Observational Study |
| Outcome | Psychotic, bipolar, depressive, and anxiety disorders |
| Results | Cannabis use doubled the risk of psychotic and bipolar disorders. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus database of over 200 million research papers using targeted queries. The following search queries were employed to identify relevant research:
- teen cannabis use mental illness risk
- marijuana psychotic disorder association
- bipolar disorder cannabis consumption impact
The table below summarizes key topics and findings from related studies:
| Topic | Key Findings |
|---|---|
| Does adolescent cannabis use increase risk of psychosis and other psychiatric disorders? | - Multiple longitudinal and meta-analytic studies report that adolescent cannabis use is associated with increased risk of developing psychotic disorders, including schizophrenia, and that risk increases with frequency and potency of use 3 6 7 8 10 13. - Some evidence also links early cannabis use to later depression, suicidality, and mania, though findings for anxiety and depression are less consistent 1 4 11 13. |
| How does cannabis potency and frequency impact mental health outcomes? | - High-potency cannabis and frequent use are associated with greater risk for psychosis and cannabis use problems in adolescents and young adults 2 7 8. - Use of high-THC/low-CBD cannabis is particularly implicated in elevated risk for psychotic and manic symptoms 8 13. |
| What is the association between cannabis use and mood disorders (bipolar, depression)? | - Cannabis use may worsen the course of bipolar disorder and increase the risk of mania and suicidality, but evidence for depression and anxiety is more mixed 1 11 12 13 14 15. - Individuals with bipolar disorder are more likely to use cannabis, and cannabis use is linked to greater disability and more severe clinical outcomes in this group 12 14 15. |
| What are the confounding factors and limitations in this research area? | - Some studies note substantial confounding from pre-existing mental health conditions, other substance use, and environmental factors, making causal inference challenging 6 9 13. - Differences in study design, reporting, and control of confounders partly explain variability in findings, especially for depression and anxiety outcomes 6 13 15. |
Does adolescent cannabis use increase risk of psychosis and other psychiatric disorders?
A substantial body of research supports the association between adolescent cannabis use and increased risk for psychotic outcomes, with several longitudinal studies demonstrating that risk is elevated even after accounting for baseline symptoms and family history 3 6 7 8 10 13. The magnitude of risk is often greater among those who use cannabis more frequently or at a younger age. The new study strengthens this evidence by documenting a doubling of risk for psychotic and bipolar disorders in a large, diverse cohort.
- Meta-analyses and systematic reviews consistently find higher rates of psychosis among adolescent cannabis users, with some suggesting a dose-response effect 6 7 10 13.
- Early initiation and frequent use further elevate risk, and high-potency cannabis may account for a substantial proportion of first-episode psychosis cases in some regions 3 8.
- Some studies also report increased risk for depression, suicidality, and mania, though findings for anxiety and depressive disorders are less robust 1 4 11 13.
- The new study’s findings align with previous research in showing increased risk for multiple psychiatric outcomes, but its large sample and broad inclusion criteria provide stronger evidence for these associations 3 6 7 8 10 13.
How does cannabis potency and frequency impact mental health outcomes?
Recent studies have emphasized that not only the presence but also the potency and frequency of cannabis use are critical determinants of mental health risk. High-potency cannabis and frequent use have been linked to greater likelihood of psychotic disorders and cannabis-related problems in young people 2 7 8 13. The increase in THC concentrations in available products, as noted in the new study, may exacerbate these risks.
- Adolescents reporting use of high-potency cannabis have higher odds of psychosis, anxiety disorders, and cannabis use problems, independent of use frequency 2 7 8 13.
- The prevalence of high-THC cannabis products has increased in recent years, paralleling trends in hospitalizations for psychotic episodes 8 13.
- Dose-response relationships have been observed, with daily or heavy use conferring the highest risk 7 8 13.
- The new study’s documentation of increased risk with even any past-year use suggests that both potency and frequency may play roles, and that risks are not confined to heavy users 2 7 8 13.
What is the association between cannabis use and mood disorders (bipolar, depression)?
While the association between cannabis and psychosis is well-established, links to mood disorders are less clear and often confounded by pre-existing conditions. Several studies indicate that cannabis use can worsen outcomes in bipolar disorder and may increase risk for mania, with less consistent evidence for depression and anxiety 1 11 12 13 14 15. The new study’s finding of doubled risk for bipolar disorders adds weight to concerns about mood outcomes.
- Cannabis use is associated with increased risk of manic symptoms and worse clinical outcomes in individuals with bipolar disorder 11 12 14 15.
- Evidence for an increased risk of depression and anxiety is more mixed, with some meta-analyses finding modest associations and others emphasizing confounding or reverse causality 1 13 15.
- Cannabis use is common among those with mood disorders, and problematic use is more prevalent in these groups 12 14 15.
- The new study supports a link between adolescent cannabis use and both bipolar and depressive disorders, contributing to ongoing debate about causality and the direction of effects 1 11 12 13 14 15.
What are the confounding factors and limitations in this research area?
A persistent challenge in cannabis and mental health research is disentangling the direct effects of cannabis from confounding variables such as pre-existing mental health conditions, concurrent substance use, genetic vulnerability, and social environment. While many studies adjust for some confounders, residual confounding remains a limitation and may partly explain inconsistent findings, especially for depression and anxiety 6 9 13 15.
- Confounding by indication (e.g., self-medication for early symptoms) and lack of control for other substance use or environmental factors are common issues 6 9 13.
- Adjusting for these confounders often attenuates observed associations, highlighting the need for well-controlled longitudinal studies 6 9 13 15.
- The new study controlled for prior mental health conditions and substance use, but residual confounding cannot be ruled out 6 9 13 15.
- Disparities in cannabis use and mental health outcomes by socioeconomic status and neighborhood deprivation, as observed in the new study, further complicate interpretation and call for targeted prevention efforts 6 9 13 15.
Future Research Questions
Despite growing evidence linking adolescent cannabis use to later psychiatric disorders, important questions remain about causality, mechanisms, high-potency products, and effective prevention. Future research should address these gaps to inform public health policies and clinical practice.
| Research Question | Relevance |
|---|---|
| What are the mechanisms by which adolescent cannabis use increases risk for psychotic and bipolar disorders? | Understanding the neurobiological and psychosocial pathways underlying the association could guide prevention and intervention strategies, and help distinguish causal effects from confounding 4 13 15. |
| Does reducing THC potency in cannabis products lower the incidence of psychiatric disorders among adolescents? | Given the link between high-potency cannabis and increased risk of psychosis, evaluating the impact of THC regulation could inform policy and harm reduction efforts 2 7 8 13. |
| How do socioeconomic and environmental factors moderate the relationship between cannabis use and mental illness in youth? | Disparities in cannabis use and mental health outcomes suggest that social determinants may influence risk, and targeted interventions may be needed for vulnerable populations 5 6 9. |
| Are there genetic or neurodevelopmental factors that increase vulnerability to cannabis-related psychiatric disorders? | Identifying individual differences in susceptibility could enable precision prevention and early identification of at-risk youth 4 13 15. |
| What prevention or treatment approaches are effective for reducing adolescent cannabis use and its mental health consequences? | There is a need to develop, evaluate, and implement interventions that can prevent early cannabis use and mitigate its mental health impacts, especially as legalization expands access 4 5 15. |